Bharat Biotech claims to have developed world's first Zika vaccine

Image
ANI Hyderabad
Last Updated : Feb 03 2016 | 11:22 PM IST

Even as US media reported a rare case of the Zika virus being "transmitted through sex, and not through mosquito bite", Bharat Biotech International Limited on Wednesday claimed to have developed Zika vaccine.

Chairman and Managing Director of Bharat Biotech International Dr. Krishna Ella told ANI, "We have been working on Zika vaccine for last more than 15 months. The reason we are working, because we have been working on Chikungunya vaccine. We have made a vaccine, which is under clinical trial. We have got two patterns. So, we thought if Chikungunya comes to India, then what is next. So, naturally the same mosquitoes, which transmit Chikungunya, is likely to bring Zika. That's how we started working on Zika vaccine."

"We have developed the vaccine and pro vaccine candidate. We filed a patent in July 2015. Probably, this was the first patent filed in July 2015, as nobody has filed before that," said Dr. Ella.

When asked what sort of help his company received from the Government in developing vaccines, he said, "We are going to ask for some Government help, we don't want any money from the Government, but we want the Government help us on the strategy on the regulatory issues, and the clinical trial issue. If they can help us, we can make it faster."

When asked how global market would react to it, he said, "We are not interested in what people think and do, and all that, what we believe in the public heath point of view. A major philosophy of our company is to work on neglected disease. Usually multinationals work on a product which got a global demand, but we work on neglected disease, which is more regional specific. We believe in it and we work on that only."

The Centres for Disease Control (CDC) claimed a patient in Dallas was infected after having sexual contact with an infected individual, who returned from a country where Zika virus is present.

The World Health Organisation on Monday had declared it an international emergency over the explosive spread of the mosquito-borne virus.

The Indian government had also issued guidelines on Tuesday, following epidemic in Brazil and in other South American countries.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 03 2016 | 11:15 PM IST

Next Story